Farber is a self-educated Austrian School economist and technical trader of precious metals and related stocks. His main vehicles are ETF's as well as options. Farber’s main interest and expertise is on the macro scale, Fed policy watching, money supply analysis and how it influences long term trends particularly in precious metals and the bond markets. His secondary interest is biotech. He writes for Seeking Alpha and am currently a columnist at CalvinAyre.com covering developments in the gambling industry.
Recent Articles By The Author
Why AIG Shares Are Set to Fall Regardless of Earnings
Shares of AIG will likely fall regardless of earnings. AIG's holdings are too heavily weighted towards corporate debt and mortgage-backed securities.
Grexit Is Irrelevant, What Matters Is the Italian Bond Market
Whether Greece decides to print its own money doesn't matter. What matters is the effect on the Italian bond market if Greece defaults outright.
Booming Chinese Stocks Headed for Bust?
The People's Bank of China is simultaneously contracting and expanding the Yuan supply in a possible attempt to preserve the status quo. If so, the Chinese stocks may have topped.
Why Stocks Are Now Going Through One of the Most Dangerous Periods of the Year
From a monetary standpoint, the period of mid-April through September is the most dangerous part of the year for the markets. Here's why.
One Word to Describe Fed Chair Yellen Warning of 'Quite High' Stock Prices?
Janet Yellen is the only latest Central Banker to warn of high stock prices. Perhaps central banks around the world should stop buying so many stocks if they're so worried.
Whether It's Yellen or Fischer Leading the Fed, a June Rate Hike Is Very Possible
Yellen and Fischer are focusing on unemployment and inflation over growth to time a rate hike. With unemployment headed down and inflation up, a June rate hike is still possible.
Why a Greek Default Is Becoming More Likely and Italy Needs to Worry
Greece's government claims €2.5 billion will be collected from a measure to seize cash from local governments. But is that true? And will it be enough?
Jim Cramer Thinks This Big Biotech Stock Can 'Power Higher'
Cramer has been a big believer in Opko Health, which has been on a run since Pfizer put down nearly $300 million for one of its drugs. More upside possible?
Greek Prime Minister Tsipras Will Have to Choose Between Politics and Economics on Monday
Greece looks set to get kicked out of the Eurozone in a matter of days or weeks. Here's why, and here's what you can do to prepare.
Japan's Stock Market Nearing Top, Downturn Imminent: 2 ETFs to Short
The Nikkei has been chugging higher ever since Abenomics began, but direct BOJ asset purchases in the Japanese stock market may be soon coming to an end.